Doctors warn travellers of vaccine shortage for deadly typhoid fever

• Shortage follows a recall by one pharmaceutical company of 88 percent of their typhoid vaccine stock in October
• Typhoid fever happens mostly in developing nations in areas with poor sanitation
• Proves fatal in as much as 30 percent of cases if left without treatment

By Claire Bates

Released: 11:54 GMT, 26 December 2012

Travellers getting away the British winter to exotic places may find it difficult to get immunised against typhoid, doctors have cautioned.

There's a United kingdom lack of the vaccine for that potentially lethal disease, carrying out a recall by pharmaceutical company of 88 percent of their stock.

Now vacationers have found that although the immunisation is generally provided totally free by local GP surgical procedures most are drained from the vaccine.

Nobody is keen on injections. However, many vacationers may struggle to obtain the vaccine they require for typhoid fever prior to going abroad

Typhoid fever are available through the third world, most generally in South Asia and East Asia. The United kingdom see around 350 cases annually nearly all that are contracted by individuals coming back from a vacation to India, Pakistan and Bangladesh.

The existence-threatening microbial infection is contracted from contaminated food or water and it is observed in areas with poor sanitation.

More...

• Simple eye scan can predict how rapidly Ms patients will decline
• Teen with spina bifida who had been told to 'get accustomed to a wheelchair' walks again after pioneering operation

It may cause serious complications for example internal bleeding or splitting from the bowel and may prove fatal otherwise quickly given anti-biotics. Typhoid fever kills about 200,000 people all over the world every year.

Salmonella typhi may be the bacteria that triggers typhoid fever. Complications may include internal bleeding

Manufacturer Sanofi Pasteur MSD remembered 16 batches of Typhim Mire vaccine in October because tests found some samples were too weak.

It meant as much as 730,000 people vaccinated between The month of january 2011 and October 2012 might have received only partial protection.

'Stocks of Typhim Mire continue to be an issue which may continue in to the early a part of 2013,' a Sanofi Pasteur spokesperson told The Protector.

The shortage continues to be compounded with a decision by manufacturer GlaxoSmithKline to focus on items for other childhood vaccination programmes. Its typhoid vaccine, Typherix, won't be available until Summer time 2014.

Reviews also claim that travel treatment centers, which charge around ?25 per vaccination have only stocks from the dental vaccine Vivotif. Its usefulness is reduced if your patient can also be taking antimalarials or anti-biotics.

A Department of Health spokesperson, told Mail Online: 'Typhoid is rare within this country and it is usually connected with visit nations where sanitation is insufficient.

Shortage: Sanofi Pasteur needed to recall 88% of their stock of Typhim Mire in October this season

Vaccine continues to be available and we're dealing with producers to assist make sure that current supply troubles are resolved as quickly as possible.'

Vacationers will also help themselves by consuming only canned water and staying away from raw veggies and drinks with ice.